Actuate Therapeutics, Inc. Financial Overview
Actuate Therapeutics, Inc.'s market cap is currently $159.45M. The company's EPS TTM is $-1.406; its P/E ratio is -5.80; Actuate Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.